Lundbeck
HLUN-B.CO
#2346
Rank
A$9.80 B
Marketcap
$10.13
Share price
0.98%
Change (1 day)
21.37%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.53. In 2022 the company made an earnings per share (EPS) of $0.40 a decrease over its 2021 EPS that were of $0.91.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5332.2%
2022$0.40-55.47%
2021$0.91-51.83%
2020$1.88-28.01%
2019$2.61-44.08%
2018$4.6751.94%
2017$3.08126.64%
2016$1.36-120.84%
2015-$6.515622.18%
2014-$0.11-110.03%
2013$1.13-28.08%
2012$1.58-52.1%
2011$3.29-1.31%
2010$3.3415.61%
2009$2.89